Target intelligence / Profile preview

Sorting nexin-17 (SNX17)

Target
SNX17
Molecular classification
Other (Sorting nexin family, Contains PX (Phox homology) domain, Contains FERM (band 4.1/ezrin/radixin/moesin) domain, Endosomal trafficking/regulatory protein)
01

Overview

Sorting nexin-17 (SNX17) is a member of the sorting nexin family, characterized by the presence of a PX (phox homology) domain enabling binding to phosphoinositide-containing membranes, especially phosphatidylinositol 3-phosphate in early endosomes[1][2][3][4][5]. SNX17 plays a key role in intracellular protein trafficking, particularly in the sorting and recycling of certain transmembrane proteins such as members of the low-density lipoprotein receptor (LDLR) family, P-selectin, and integrins[1][2][3][4]. It achieves these functions via a truncated FERM domain and unique C-terminus, recognizing NPxY/NxxY/NxxF motifs in the cytoplasmic tails of its cargo, and through interaction with the Retriever complex[2][4][5]. SNX17 is not considered a classical drug target or therapeutic receptor but is fundamental in maintaining plasma membrane proteome composition and endosomal sorting pathways[2][3][4][5]. Altered SNX17 function may influence receptor turnover and cell surface protein displays, with potential indirect consequences for cellular homeostasis and disease, although direct therapeutic application or established disease associations remain limited[2][4][5]. Key details summarized from current molecular biology and structural studies indicate SNX17 functions in the recognition and recycling of specific protein cargoes, impacting receptor availability and plasma membrane dynamics, but it is not yet an established direct pharmacological target[2][4][5].

Other names
SNX17KIAA0064sorting nexin 17sorting nexin-17
02

Biological functions

Intracellular traffickingEndosomal recycling and sorting of membrane proteinsRegulation of plasma membrane protein composition
03

Disease associations

Other (not directly linked to major disease categories such as cancer, inflammation, neurodegenerative disease, cardiovascular disease, or infection, but implicated in cargo sorting processes that may influence disease states)

Beyond the preview

Go deeper on Sorting nexin-17 (SNX17).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sorting nexin-17 (SNX17).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call